ArticleESC heart failure2026
Bridging the gap in heart failure management: the effect of a cross-disciplinary intervention on guidelines-directed medical therapy in primary care.
Article in ESC heart failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
BACKGROUND AND
aimsGuideline-directed medical therapy (GDMT) for heart failure (HF) is underutilized in primary care, particularly among older adults with chronic stable HF. This prospective quality improvement study, Heart Failure in Southern Sweden (HISS), evaluated the impact of a cross-disciplinary implementation project combining cardiology and primary care expertise to enhance GDMT adherence and reduce healthcare contacts.
methodsTwenty primary health care centres in southern Sweden participated, recruiting 587 patients diagnosed with HF (mean age 79 years) between 2021 and 2023. The intervention involved case-based educational conferences with cardiologists and general practitioners, individualized treatment recommendations, and follow-up monitoring. Medication use and healthcare contacts were assessed 6 months before and after the intervention.
resultsGDMT use (defined as quadruple therapy according to the 2022 guidelines) increased from 20.8% at baseline to 37.7% post-intervention (P < .001) among patients with HF with reduced ejection fraction (HFrEF), and from 12.4% to 17.8% (P = .020) among patients with mildly reduced ejection fraction (HFmrEF). The uptake of sodium-glucose co-transporter-2 inhibitors (SGLT2i) improved significantly across all HF types, while angiotensin receptor-neprilysin inhibitors (ARNI) increased among HFrEF patients. Beta-blocker use declined in patients with HF with preserved ejection fraction. The total number of ambulatory healthcare contacts decreased following the intervention, while the hospitalizations remained unchanged.
conclusionsThe HISS study demonstrates that a cross-disciplinary, case-based educational intervention was associated with improved GDMT adherence (especially SGLT2i and ARNI) and reduced ambulatory healthcare utilization in primary care patients with chronic stable HF. These findings underscore the importance of bridging the gap between specialist and primary care to optimize HF management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.